MAPT and Alzheimer disease: Age-associated decline in proteostasis is closely linked to neurodegenerative disorders, such as Alzheimer’s disease (AD) that is characterized by synaptic alteration and loss owing to the accumulation of amyloid beta (Aβ) plaques and tau neurofibrillary tangles [1].